All sites C00-96,D32-33,D42-43,D45-47,D76 182 88.1 4.0 2.3 2.4 3.2
Mouth, pharynx C00-14 3 100.0 - - - -
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 37 77.0 7.1 3.8 5.5 6.6
  Oesophagus C15 1 85.7 - - 14.3 -
  Stomach C16 2 83.3 16.7 - - -
  Small intestine C17 0 100.0 - - - -
  Colon C18 15 100.0 - - - -
  Rectum, rectosigmoid C19-20 3 100.0 - - - -
  Anus C21 1 66.7 33.3 - - -
  Liver C22 2 50.0 20.0 10.0 10.0 10.0
  Gallbladder, bile ducts C23-24 3 38.5 7.7 15.4 15.4 23.1
  Pancreas C25 9 46.7 15.6 8.9 11.1 17.8
  Other digestive organs C26 0 50.0 - - 50.0 -
Respiratory organs C30-39 14 67.1 17.1 5.7 4.3 5.7
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 13 65.2 18.2 6.1 4.5 6.1
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 1 66.7 - 33.3 - -
Melanoma of the skin C43 4 100.0 - - - -
Skin, non-melanoma C44 9 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 100.0 - - - -
Breast C50 59 98.3 0.7 0.3 0.3 0.3
Female genital organs C51-58 22 97.3 - - 2.7 -
  Cervix uteri C53 3 100.0 - - - -
  Corpus uteri C54 11 100.0 - - - -
  Uterus, other C55,C58 0 - - - 100.0 -
  Ovary C56 5 96.0 - - 4.0 -
  Other female genital C51-52,C57 3 100.0 - - - -
Urinary organs C64-68 9 93.6 2.1 - - 4.3
  Kidney C64 5 92.0 4.0 - - 4.0
  Bladder and urinary tract2 C65-68 4 95.5 - - - 4.5
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 5 88.9 - 3.7 3.7 3.7
Thyroid gland C73 2 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 3 18.8 25.0 31.3 12.5 12.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 13 76.2 6.3 3.2 3.2 11.1
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 5 100.0 - - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 2 63.6 18.2 9.1 - 9.1
  Leukaemia C91-95 3 70.6 5.9 5.9 5.9 11.8
  Myelodysplastic syndromes D46 1 33.3 16.7 - 16.7 33.3
  Myeloproliferaitive neoplasms D45,D47 1 33.3 - - - 66.7
Not included above
  Carcinoma in situ of the breast D05 3 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 16 100.0 - - - -
  Borderline tumour of the ovary D39 3 82.4 - - - 17.6
  Basal cell carcinoma of the skin 46 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.